{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:33:20Z","timestamp":1780328000079,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Clinical studies aimed at identifying effective and simple prognostic markers for gastric cancer are still being carried out. Inflammatory prognostic index (IPI) is being recognized as a promising prognostic marker in patients with Non-Small Cell Lung Cancer. To evaluate the prognostic utility of IPI in stage 4 gastric cancer. A total of 152 patients with stage 4 gastric cancer, whose laboratory parameters, progression-free survival (PFS) and overall survival (OS) data could be accessed, were evaluated. Kaplan Meier analysis was used for survival analyses. Hazard ratios were expressed with 95% CI values. All methods were performed in accordance with the relevant guidelines and regulations. Study was approved by the Manisa Celal Bayar University\u2019s Non-Invasive Clinical Research Ethics Committee (approval No. E-85252386-050.04.04-49119, date: 22.03.2021). We confirm that all methods were performed in accordance with relevant named guidelines and regulations. Median age at diagnosis was 63\u00a0years (range: 32\u201388). The number of patients who received first-line chemotherapy was 129 (84.9%). Median PFS with first-line treatment was 5.3\u00a0months, while it was 3.3\u00a0months with second-line treatment. Median OS was 9.4\u00a0months. Median IPI score was 22.2. We evaluated IPI score for its value in detecting survival status with ROC analysis and identified an IPI cut-off score of 14.6. Low IPI score was significantly associated with longer PFS and OS compared to high IPI (PFS in high vs. low IPI, 3.6 vs. 7\u00a0months;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) (OS in high vs. low IPI, 6.6 vs. 14.2\u00a0months;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). IPI score can be an independent prognostic index that is inexpensive, easy to access and evaluate for patients with metastatic gastric cancer, and may be useful in predicting survival in daily practice.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-34778-5","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T11:02:21Z","timestamp":1683889341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The inflammatory prognostic index as a potential predictor of prognosis in metastatic gastric cancer"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-5432","authenticated-orcid":false,"given":"Ahmet","family":"Ozveren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-7574","authenticated-orcid":false,"given":"Atike Pinar","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9317-942X","authenticated-orcid":false,"given":"Ferhat","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"issue":"3","key":"34778_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","volume":"12","author":"KD Crew","year":"2006","unstructured":"Crew, K. D. & Neugut, A. I. Epidemiology of gastric cancer. World J Gastroenterol: WJG 12(3), 354 (2006).","journal-title":"World J Gastroenterol: WJG"},{"issue":"4","key":"34778_CR2","doi-asserted-by":"publisher","first-page":"e022393","DOI":"10.1136\/bmjopen-2018-022393","volume":"8","author":"RB Hines","year":"2018","unstructured":"Hines, R. B. et al. Post-treatment surveillance testing of patients with colorectal cancer and the association with survival: Protocol for a retrospective cohort study of the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. BMJ Open 8(4), e022393 (2018).","journal-title":"BMJ Open"},{"issue":"6","key":"34778_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140(6), 883\u2013899 (2010).","journal-title":"Cell"},{"issue":"12","key":"34778_CR4","first-page":"1651","volume":"84","author":"H Allgayer","year":"1997","unstructured":"Allgayer, H., Heiss, M. & Schildberg, F. Prognostic factors in gastric cancer. J. Br. Surg. 84(12), 1651\u20131664 (1997).","journal-title":"J. Br. Surg."},{"issue":"6","key":"34778_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340(6), 448\u2013454 (1999).","journal-title":"N. Engl. J. Med."},{"issue":"7203","key":"34778_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454(7203), 436\u2013444 (2008).","journal-title":"Nature"},{"issue":"9","key":"34778_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s11745-013-3816-0","volume":"48","author":"MC Mocellin","year":"2013","unstructured":"Mocellin, M. C. et al. Fish oil decreases C-reactive protein\/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients. Lipids 48(9), 879\u2013888 (2013).","journal-title":"Lipids"},{"issue":"1","key":"34778_CR8","first-page":"5","volume":"102","author":"R Zahorec","year":"2001","unstructured":"Zahorec, R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl. Lek. Listy 102(1), 5\u201314 (2001).","journal-title":"Bratisl. Lek. Listy"},{"issue":"6","key":"34778_CR9","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton, A. J. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis. JNCI J. Natl. Cancer Inst. 106(6), dju124 (2014).","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"9","key":"34778_CR10","doi-asserted-by":"publisher","first-page":"e0184412","DOI":"10.1371\/journal.pone.0184412","volume":"12","author":"J Jin","year":"2017","unstructured":"Jin, J., Hu, K., Zhou, Y. & Li, W. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis. PLoS ONE 12(9), e0184412 (2017).","journal-title":"PLoS ONE"},{"issue":"1","key":"34778_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.athoracsur.2017.01.085","volume":"104","author":"S Okada","year":"2017","unstructured":"Okada, S. et al. Clinical significance of prognostic nutritional index after surgical treatment in lung cancer. Ann. Thorac. Surg. 104(1), 296\u2013302 (2017).","journal-title":"Ann. Thorac. Surg."},{"issue":"12","key":"34778_CR12","first-page":"5101","volume":"17","author":"N Dirican","year":"2016","unstructured":"Dirican, N. et al. A new inflammatory prognostic index, based on C-reactive protein, the neutrophil to lymphocyte ratio and serum albumin is useful for predicting prognosis in non-small cell lung cancer cases. Asian Pac. J. Cancer Prevent.: APJCP 17(12), 5101 (2016).","journal-title":"Asian Pac. J. Cancer Prevent.: APJCP"},{"key":"34778_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11523-020-00723-z","volume":"15","author":"V Formica","year":"2020","unstructured":"Formica, V. et al. Gastric inflammatory prognostic index (GIPI) in patients with metastatic gastro-esophageal Junction\/Gastric Cancer treated with PD-1\/PD-L1 Immune checkpoint inhibitors. Target. Oncol. 15, 327\u2013336 (2020).","journal-title":"Target. Oncol."},{"issue":"10","key":"34778_CR14","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.7314\/APJCP.2013.14.10.5735","volume":"14","author":"Q Yu","year":"2013","unstructured":"Yu, Q. et al. Prognostic role of C-reactive protein in gastric cancer: A meta-analysis. Asian Pac. J. Cancer Prev. 14(10), 5735\u20135740 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"34778_CR15","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s00268-010-0641-y","volume":"34","author":"AB Crumley","year":"2010","unstructured":"Crumley, A. B., Stuart, R. C., McKernan, M. & McMillan, D. C. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?. World J. Surg. 34(10), 2393\u20132398 (2010).","journal-title":"World J. Surg."},{"issue":"5","key":"34778_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/SLA.0000000000001445","volume":"262","author":"HM Heneghan","year":"2015","unstructured":"Heneghan, H. M. et al. Prospective study of malabsorption and malnutrition after esophageal and gastric cancer surgery. Ann. Surg. 262(5), 803\u2013808 (2015).","journal-title":"Ann. Surg."},{"issue":"3\u20134","key":"34778_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000127412","volume":"73","author":"T Yamanaka","year":"2007","unstructured":"Yamanaka, T. et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73(3\u20134), 215\u2013220 (2007).","journal-title":"Oncology"},{"issue":"2","key":"34778_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/SLA.0b013e3181b16e24","volume":"250","author":"M Ishizuka","year":"2009","unstructured":"Ishizuka, M., Nagata, H., Takagi, K. & Kubota, K. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann. Surg. 250(2), 268\u2013272 (2009).","journal-title":"Ann. Surg."},{"issue":"6","key":"34778_CR19","first-page":"7417","volume":"14","author":"M Mao","year":"2017","unstructured":"Mao, M. et al. C-reactive protein\/albumin and neutrophil\/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Oncol. Lett. 14(6), 7417\u20137424 (2017).","journal-title":"Oncol. Lett."},{"issue":"1","key":"34778_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4103\/jcrt.jcrt_1902_20","volume":"18","author":"M Yilmaz","year":"2022","unstructured":"Yilmaz, M., Baran, A. & Yilmaz, M. K. Predictive significance of inflammatory indexes in metastatic nonsmall cell lung cancer patients treated with platinum-doublet chemotherapy. J. Cancer Res. Ther. 18(1), 220 (2022).","journal-title":"J. Cancer Res. Ther."},{"issue":"3","key":"34778_CR21","first-page":"4017","volume":"15","author":"H Sun","year":"2018","unstructured":"Sun, H., Hu, P., Du, J. & Wang, X. Predictive value of inflammatory indexes on the chemotherapeutic response in patients with unresectable lung cancer: A retrospective study. Oncol. Lett. 15(3), 4017\u20134025 (2018).","journal-title":"Oncol. Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34778-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34778-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34778-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T11:23:39Z","timestamp":1683890619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34778-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34778"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34778-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1264323\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"15 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7755"}}